Health Discovery (HDVY) Stock Price, News & Analysis

Company Overview

Health Discovery Corporation is a biotechnology company focused on developing molecular diagnostic tests and precision-medicine technologies. Its research has centered on analyzing gene-expression and other genomic data to identify disease-related patterns that may support earlier detection, diagnosis, prognosis and treatment selection.

The company’s technology platform has been based on proprietary bioinformatics and machine-learning methods, including support-vector-machine algorithms. Historically, Health Discovery Corporation has pursued diagnostic applications in areas such as breast cancer, prostate cancer and other diseases, working through research, licensing and commercialization arrangements. The availability and commercial status of specific tests may vary, and publicly available information about the company’s current product portfolio is limited.

Health Discovery Corporation has historically been associated with operations in the United States, including Savannah, Georgia. Information about its current leadership, active programs and geographic operations is limited in publicly available sources.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 24,715 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 6/30/2020
• Today: 10/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:HDVY
• CIK: 1141788
• Web: www.healthdiscoverycorp.com
• Phone: (404) 566-4865
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.23